The Indian government plans to announce a new list of cancer drugs for trade margin rationalisation today. Union Health Minister JP Nadda will make the announcement just ahead of a Supreme Court hearing on October 12. This decision comes after concerns regarding the price gap between retailer prices and MRP of some cancer medications. Trade margins were capped previously, leading to significant price reductions on several anti-cancer drugs.